Modified McKeown Minimally Invasive Esophagectomy for Esophageal Cancer: A 5-Year Retrospective Study of 142 Patients in a Single Institution

Abstract

BackgroundTo achieve decreased invasiveness and lower morbidity, minimally invasive esophagectomy (MIE) was introduced in 1997 for localized esophageal cancer. The combined thoracoscopic-laparoscopic esophagectomy (left neck anastomosis, defined as the McKeown MIE procedure) has been performed since 2007 at our institution. From 2007 to 2011, our institution subsequently evolved as a high-volume MIE center in China. We aim to share our experience with MIE, and have evaluated the outcomes of 142 patients.MethodsWe retrospectively reviewed 142 consecutive patients who had presented with esophageal cancer undergoing McKeown MIE from July 2007 to December 2011. The procedure, surgical outcomes, disease-free and overall survival of these cases were assessed.ResultsThe average total procedure time was 270.5±28.1 min. The median operation time for thoracoscopy was 81.5±14.6 min and for laparoscopy was 63.8±9.1 min. The average blood loss associated with thoracoscopy was 123.8±39.2 ml, and for laparoscopic procedures was 49.9±14.3 ml. The median number of lymph nodes retrieved was 22.8. The 30 day mortality rate was 0.7%. Major surgical complications occurred in 24.6% and major non-surgical complications occurred in 18.3% of these patients. The median DFS and OS were 36.0±2.6 months and 43.0±3.4 months respectively.ConclusionsSurgical and oncological outcomes following McKeown MIE for esophageal cancer were acceptable and comparable with those of open-McKeown esophagectomy. The procedure was both feasible and safe – properties that can be consolidated by experience.

The impact of operative approaches on outcomes of middle and lower third esophageal squamous cell carcinoma

“…However, in some large medical center with advanced medical technique, minimal invasive Ivor Lewis approach gained more popularity owning to lessened postoperative inflammatory reaction despite greater cost (20,21). There was no difference in 3-year OS between 2 approaches in our study.…”

Effects of preemptive analgesia with flurbiprofen ester on lymphocytes and natural killer cells in patients undergoing esophagectomy: A randomized controlled pilot study

“…A surgical trauma‐induced stress response can lead to the inhibition of cellular immunity in patients . With the development of minimally invasive endoscopic techniques, thoracoscopic esophageal resection results in less trauma, fewer complications, and better long‐term effects . In this study, traditional thoracotomy and minimally invasive endoscopic surgery were examined and the results showed that the two surgical procedures had the same effect on immune function; however long‐term differences were not studied.…”

Effective Mediastinal Lymphadenectomy for Esophageal Cancer Using Slender Tracheal Forceps in Prone Position Thoracoscopic Esophagectomy

“…Thoracoscopic surgery for esophageal cancer is often performed as a type of minimally invasive surgery (13)(14)(15)(16)(17). Although its importance as a minimally invasive procedure has been controversial to date, the reduction in blood loss that results from being able to recognize fine structure is a merit of thoracoscopic surgery (18).…”